Top 5 Stock Picks of Steve Zheng’s Deepcurrents Investment Group

4. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Deepcurrents Investment Group’s Stake Value: $12.85 million

Percentage of Deepcurrents Investment Group’s 13F portfolio: 0.38%

Total Number of Hedge Fund Holders: 34

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a biopharmaceutical company that deals in the development and commercialization of pharmaceutical products in the fields of narcolepsy, oncology, pain, and psychiatry.

On November 19, Goldman Sachs reinstated its coverage of Jazz Pharmaceuticals plc (NASDAQ: JAZZ) with a ‘Buy’ rating, setting a $198 price target.

In Q3 2021, the firm posted an EPS of $4.20, beating estimates by $0.89. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) raked in $838.12 million in revenue for the quarter, exceeding analysts’ expectations by $6.06 million.

As of the second quarter of 2021, 34 out of 873 hedge funds tracked by Insider Monkey reported holding positions worth $1.49 billion in Jazz Pharmaceuticals plc (NASDAQ: JAZZ), up from the previous quarter where 37 hedge funds held $1.26 billion worth of stocks in the company.